Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$195,524
-$455,641 QoQ
Shares Held
777
-74.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#3,968
of 4,153 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CONTRAVISORY INVESTMENT MANAGEMENT, INC. holds $32,212,697 across 8 Drug Manufacturers - General names. ABBV ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
76,643 | $9,848,625 | |
| 2 | BIIB |
Biogen Inc.
|
44,329 | $9,577,723 | |
| 3 | PFE |
Pfizer Inc
|
299,290 | $7,206,903 | |
| 4 | LLY |
ELI LILLY & Co
|
2,955 | $3,544,315 | |
| 5 | JNJ |
Johnson & Johnson
|
4,341 | $1,102,483 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,737 | $724,812 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
777 | $195,524 | |
| 8 | AMGN |
Amgen Inc
|
34 | $12,312 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $195,524 | 777 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $651,165 | 2,994 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $812,510 | 3,556 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $895,828 | 3,869 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $941,093 | 5,070 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $1,028,743 | 4,910 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $7,641 | 43 | Shares | Sole | 2025-01-14 | |
| 2023-06-30 | $347,064 | 2,576 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $516,358 | 3,240 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $519,252 | 3,213 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $385,853 | 2,875 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $422,874 | 2,761 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $105,371 | 650 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $88,010 | 650 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $70,115 | 650 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $73,216 | 650 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $70,343 | 650 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $69,647 | 650 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $5,880,967 | 67,142 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $6,665,931 | 67,895 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $49,523 | 650 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||